Biggest News Aggregation in the World
📰 Practice Guidelines News

Page 38 - Practice Guidelines News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Practice Guidelines. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Janssen Receives Positive CHMP Opinion for IMBRUVICA (ibrutinib) in a Fixed-Duration Combination Regimen for Adult Patients with Previously Untreated Chronic Lymphocytic Leukaemia (CLL)

The positive opinion is based on Phase 3 GLOW and Phase 2 CAPTIVATE study results, which investigated the efficacy and safety of ibrutinib plus venetoclax in patients with previously untreated CLL1
United States Craig Tendler Jenni Mildon Edmond Chan Hematology Am Soc Hematol Educ Program Janssen Biotech Inc

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science